Nicolas Penel

基本信息

Career Trajectory

Bio

His main interests are clinical management of rare cancers, especially sarcomas and cancers of unknown primary site and methodology of early phase clinical trials. He is coordinator of numerous clinical trials assessing new drugs in rare cancers and urological cancers. Prof Penel is a member of the American Society of Clinical Oncology, the European Society for Medical Oncology and the French Society of Cancer.

Prof Penel is the author or co-author of over 240 publications in medical oncology.

Research Interests

Papers共 872 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Supplementary Table S3 from AMG 193, a Clinical Stage MTA-Cooperative PRMT5 Inhibitor, Drives Antitumor Activity Preclinically and in Patients with MTAP-Deleted Cancers

Brian Belmontes, Katherine K. Slemmons, Chun Su, Siyuan Liu,Antonia N. Policheni,Jodi Moriguchi, Hong Tan, Fang Xie, Daniel Andrew Aiello,Yajing Yang, Raul Lazaro,Famke Aeffner,Matthew G. Rees,Melissa M. Ronan, Jennifer A. Roth,Mikkel Vestergaard,Sanne Cowland, Jan Andersson,Ian Sarvary, Qing Chen, Pooja Sharma,Patricia Lopez,Nuria Tamayo,Liping H. Pettus,Sudipa Ghimire-Rijal,Susmith Mukund,Jennifer R. Allen,Jason DeVoss,Angela Coxon,Jordi Rodon,François Ghiringhelli,Nicolas Penel,Hans Prenen,Sanne Glad,Chen-Hua Chuang, Kiana Keyvanjah,Danielle M. Townsley, John R. Butler,Matthew P. Bourbeau,Sean Caenepeel,Paul E. Hughes

crossref（2025）

Cited0Views0Bibtex

Supplementary Table S9 from AMG 193, a Clinical Stage MTA-Cooperative PRMT5 Inhibitor, Drives Antitumor Activity Preclinically and in Patients with MTAP-Deleted Cancers

Brian Belmontes, Katherine K. Slemmons, Chun Su, Siyuan Liu,Antonia N. Policheni,Jodi Moriguchi,Hong Tan, Fang Xie, Daniel Andrew Aiello,Yajing Yang, Raul Lazaro,Famke Aeffner,Matthew G. Rees,Melissa M. Ronan,Jennifer A. Roth,Mikkel Vestergaard,Sanne Cowland, Jan Andersson,Ian Sarvary, Qing Chen, Pooja Sharma,Patricia Lopez,Nuria Tamayo,Liping H. Pettus,Sudipa Ghimire-Rijal,Susmith Mukund, Jennifer R. Allen,Jason DeVoss,Angela Coxon,Jordi Rodon,François Ghiringhelli,Nicolas Penel,Hans Prenen,Sanne Glad,Chen-Hua Chuang, Kiana Keyvanjah,Danielle M. Townsley, John R. Butler,Matthew P. Bourbeau,Sean Caenepeel,Paul E. Hughes

crossref（2025）

Cited0Views0Bibtex

Supplementary Figure S10 from AMG 193, a Clinical Stage MTA-Cooperative PRMT5 Inhibitor, Drives Antitumor Activity Preclinically and in Patients with MTAP-Deleted Cancers

Brian Belmontes, Katherine K. Slemmons, Chun Su, Siyuan Liu,Antonia N. Policheni,Jodi Moriguchi,Hong Tan, Fang Xie, Daniel Andrew Aiello,Yajing Yang, Raul Lazaro,Famke Aeffner,Matthew G. Rees,Melissa M. Ronan, Jennifer A. Roth,Mikkel Vestergaard,Sanne Cowland, Jan Andersson,Ian Sarvary, Qing Chen, Pooja Sharma,Patricia Lopez,Nuria Tamayo,Liping H. Pettus,Sudipa Ghimire-Rijal,Susmith Mukund,Jennifer R. Allen,Jason DeVoss,Angela Coxon,Jordi Rodon,François Ghiringhelli,Nicolas Penel,Hans Prenen,Sanne Glad,Chen-Hua Chuang, Kiana Keyvanjah,Danielle M. Townsley, John R. Butler,Matthew P. Bourbeau,Sean Caenepeel,Paul E. Hughes

crossref（2025）

Cited0Views0Bibtex

Supplementary Table S7 from AMG 193, a Clinical Stage MTA-Cooperative PRMT5 Inhibitor, Drives Antitumor Activity Preclinically and in Patients with MTAP-Deleted Cancers

Brian Belmontes, Katherine K. Slemmons, Chun Su, Siyuan Liu,Antonia N. Policheni,Jodi Moriguchi,Hong Tan, Fang Xie, Daniel Andrew Aiello,Yajing Yang, Raul Lazaro,Famke Aeffner,Matthew G. Rees,Melissa M. Ronan, Jennifer A. Roth,Mikkel Vestergaard,Sanne Cowland, Jan Andersson,Ian Sarvary, Qing Chen, Pooja Sharma,Patricia Lopez,Nuria Tamayo,Liping H. Pettus,Sudipa Ghimire-Rijal,Susmith Mukund,Jennifer R. Allen,Jason DeVoss,Angela Coxon,Jordi Rodon,François Ghiringhelli,Nicolas Penel,Hans Prenen,Sanne Glad,Chen-Hua Chuang, Kiana Keyvanjah,Danielle M. Townsley, John R. Butler,Matthew P. Bourbeau,Sean Caenepeel,Paul E. Hughes

crossref（2025）

Cited0Views0Bibtex

Supplementary Figure S11 from AMG 193, a Clinical Stage MTA-Cooperative PRMT5 Inhibitor, Drives Antitumor Activity Preclinically and in Patients with MTAP-Deleted Cancers

crossref（2025）

Cited0Views0Bibtex

Primary Ovarian Leiomyosarcoma: Results from an Analysis by the French Sarcoma Group (ovarian SArcoma MAnagement – OSAMA Study)

Domenico Ferraioli,Fulvio Borella,Marie Meurer,Coriolan Lebreton,Nicolas Penel,Francois Bertucci,Emmanuelle Bompas,Antoine Italiano,Nelly Firmin,Luca Bertero,Isabelle Peyrottes,Julien Mancini,Nicolas Isambert,Christine Chevreau,Gwenael Ferron, Cristophe Perrin,Sophie Piperno-Neumann,Stefano Cosma,Patricia Pautier,Cécile Loaec

International Journal of Gynecological Cancerpp.101692, (2025)

Cited0Views0WOSBibtex

Supplementary Figure S1 from AMG 193, a Clinical Stage MTA-Cooperative PRMT5 Inhibitor, Drives Antitumor Activity Preclinically and in Patients with MTAP-Deleted Cancers

Brian Belmontes, Katherine K. Slemmons, Chun Su, Siyuan Liu,Antonia N. Policheni,Jodi Moriguchi,Hong Tan, Fang Xie, Daniel Andrew Aiello,Yajing Yang, Raul Lazaro,Famke Aeffner,Matthew G. Rees,Melissa M. Ronan, Jennifer A. Roth,Mikkel Vestergaard,Sanne Cowland, Jan Andersson,Ian Sarvary, Qing Chen, Pooja Sharma,Patricia Lopez,Nuria Tamayo,Liping H. Pettus,Sudipa Ghimire-Rijal,Susmith Mukund,Jennifer R. Allen,Jason DeVoss,Angela Coxon,Jordi Rodon,François Ghiringhelli,Nicolas Penel,Hans Prenen,Sanne Glad,Chen-Hua Chuang, Kiana Keyvanjah,Danielle M. Townsley, John R. Butler,Matthew P. Bourbeau,Sean Caenepeel,Paul E. Hughes

crossref（2025）

Cited0Views0Bibtex

Motivational Factors Influencing the Choice of Oncology As a Specialty among French Medical Students

Nicolas Penel, Pierre-Yves Cren, Christophe Ducroq, Estelle M. N. Laurent, Gabriel Choukroun,Marc Hazzan, Dominique Crie

BMC Medical Educationno. 1 (2025): 1-9

Cited0Views0WOSBibtex

Adjuvant Treatment of Gastrointestinal Stromal Tumor: State of the Art in 2025

Nicolas Penel,Axel Le Cesne, Jean-Yves Blay

European journal of cancer (Oxford, England 1990) (2025): 115473-115473

Cited0Views0WOSBibtex

Supplementary Figure S5 from AMG 193, a Clinical Stage MTA-Cooperative PRMT5 Inhibitor, Drives Antitumor Activity Preclinically and in Patients with MTAP-Deleted Cancers

crossref（2025）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn

Professor

Papers共 872 篇Author StatisticsCo-AuthorSimilar Experts